USS Investment Management Ltd Sells 10,779 Shares of Aflac Incorporated (NYSE:AFL)

USS Investment Management Ltd reduced its position in Aflac Incorporated (NYSE:AFL - Free Report) by 8.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 124,773 shares of the financial services provider's stock after selling 10,779 shares during the period. USS Investment Management Ltd's holdings in Aflac were worth $12,911,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Whipplewood Advisors LLC bought a new stake in shares of Aflac during the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Aflac in the fourth quarter worth approximately $34,000. Curio Wealth LLC bought a new stake in Aflac during the fourth quarter valued at approximately $36,000. OFI Invest Asset Management purchased a new stake in Aflac during the fourth quarter valued at approximately $38,000. Finally, Rialto Wealth Management LLC purchased a new stake in Aflac during the fourth quarter valued at approximately $41,000. Institutional investors own 67.44% of the company's stock.

Insider Activity

In other news, Director Masatoshi Koide sold 37,000 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the sale, the director now directly owns 70,992 shares in the company, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. This represents a 3.79% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 71,552 shares of company stock worth $7,609,382. 0.90% of the stock is currently owned by insiders.

Aflac Price Performance

AFL traded up $0.14 during trading on Friday, hitting $102.59. 1,641,470 shares of the company traded hands, compared to its average volume of 2,114,525. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The company has a market cap of $55.46 billion, a PE ratio of 10.69, a P/E/G ratio of 3.24 and a beta of 0.84. The stock's 50-day simple moving average is $106.85 and its two-hundred day simple moving average is $106.44. Aflac Incorporated has a 1 year low of $86.46 and a 1 year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The company's revenue for the quarter was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.66 EPS. As a group, sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be issued a dividend of $0.58 per share. The ex-dividend date is Wednesday, May 21st. This represents a $2.32 annualized dividend and a dividend yield of 2.26%. Aflac's dividend payout ratio (DPR) is 36.25%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on AFL shares. UBS Group lifted their price target on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Barclays upped their price target on Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research report on Thursday, May 1st. BMO Capital Markets started coverage on Aflac in a research report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 price objective on the stock. Piper Sandler increased their target price on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Finally, Morgan Stanley lifted their price target on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a report on Monday. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $104.57.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.